SCHEMBL1224793

SCHEMBL1224793

O=C(O)C=CCC(O)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.44
▸ GABRR1 P24046 2/20 0.44
▸ GABRR2 P28476 2/20 0.44
▸ BLM P54132 2/20 0.44
▸ GABRR3 A8MPY1 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ APEX1 P27695 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ OR51E2 Q9H255 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TP53 P04637 1/20 0.38
▸ EGLN1 Q9GZT9 1/20 0.38
▸ EGLN3 Q9H6Z9 1/20 0.38
▸ TET2 Q6N021 6/20 0.37
▸ KDM4A O75164 2/20 0.37
▸ KDM4C Q9H3R0 2/20 0.37
▸ KDM2A Q9Y2K7 2/20 0.37
▸ TET3 O43151 2/20 0.37
▸ TET1 Q8NFU7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14836590 1.00 TSHR (0.44) TSHRGABRR1GABRR2BLMGABRR3
SCHEMBL1224792 1.00 TSHR (0.44) TSHRGABRR1GABRR2BLMGABRR3
SCHEMBL14836593 1.00 TSHR (0.44) TSHRGABRR1GABRR2BLMGABRR3
SCHEMBL10044870 0.81 TSHR (0.41) TSHRGABRR1GABRR2BLMGABRR3
SCHEMBL8823395 0.79 TSHR (0.48) TSHRGABRR1GABRR2BLMGABRR3
SCHEMBL8823392 0.79 TSHR (0.48) TSHRGABRR1GABRR2BLMGABRR3
SCHEMBL28682297 0.79 — —
SCHEMBL9565293 0.75 — —
SCHEMBL9565291 0.75 — —
SCHEMBL23659094 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10415063-B2 Semi-synthetic terephthalic acid via microorganisms that produce muconic acid GENOMATICA, INC. (US) 2019-09-17 — — US disclosed
US-20180312883-A1 SEMI-SYNTHETIC TEREPHTHALIC ACID VIA MICROORGANISMS THAT PRODUCE MUCONIC ACID GENOMATICA, INC. 2018-11-01 — — US disclosed
US-10041093-B2 Semi-synthetic terephthalic acid via microorganisms that produce muconic acid GENOMATICA, INC. (US) 2018-08-07 — — US disclosed
EP-3190174-A1 SEMI-SYNTHETIC TEREPHTHALIC ACID VIA MICROORGANISMS THAT PRODUCE MUCONIC ACID Genomatica, Inc. (US) 2017-07-12 — — EP disclosed
US-20170096689-A1 SEMI-SYNTHETIC TEREPHTHALIC ACID VIA MICROORGANISMS THAT PRODUCE MUCONIC ACID GENOMATICA, INC. 2017-04-06 — — US disclosed
EP-2462221-B1 SEMI-SYNTHETIC TEREPHTHALIC ACID VIA MICROORGANISMS THAT PRODUCE MUCONIC ACID GENOMATICA INC (US) 2017-02-22 — — EP disclosed
US-9562241-B2 Semi-synthetic terephthalic acid via microorganisms that produce muconic acid GENOMATICA, INC. (US) 2017-02-07 — — US disclosed
US-20140302573-A1 SEMI-SYNTHETIC TEREPHTHALIC ACID VIA MICROORGANISMS THAT PRODUCE MUCONIC ACID GENOMATICA INC (US) 2014-10-09 — — US disclosed
US-8729294-B2 Process for producing optically active 3-substituted-3-formyl-2-hydroxypropanoic acid compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-05-20 — — US disclosed
US-20130137880-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-SUBSTITUTED-3-FORMYL-2-HYDROXYPROPANOIC ACID COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-05-30 — — US disclosed
EP-2578566-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-SUBSTITUTED-3-FORMYL-2-HYDROXYPROPANOIC ACID COMPOUND Sumitomo Chemical Company Limited (JP) 2013-04-10 — — EP disclosed
EP-2462221-A1 SEMI-SYNTHETIC TEREPHTHALIC ACID VIA MICROORGANISMS THAT PRODUCE MUCONIC ACID Genomatica, Inc. (US) 2012-06-13 — — EP disclosed
US-20110124911-A1 SEMI-SYNTHETIC TEREPHTHALIC ACID VIA MICROORGANISMS THAT PRODUCE MUCONIC ACID GENOMATICA, INC. 2011-05-26 — — US disclosed
WO-2011017560-A1 SEMI-SYNTHETIC TEREPHTHALIC ACID VIA MICROORGANISMS THAT PRODUCE MUCONIC ACID GENOMATICA, INC. (US) 2011-02-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137880-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-SUBSTITUTED-3-FORMYL-2-HYDROXYPROPANOIC ACID COMPOUND HPD, GRHPR, HAAO TSHR 4727/4885GABRR1 1660/4885GABRR2 1986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback